Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.
about
Current immunological and molecular tools for leptospirosis: diagnostics, vaccine design, and biomarkers for predicting severityDiscovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology.Characterisation of the Proteome of Leptospira interrogans Serovar Canicola as a Resource for the Identification of Common Serovar Immunogenic Proteins.Lipoproteins of bacterial pathogens.High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris.Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency.Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxinLeptospirosis vaccines.Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.The Cross-Talk between Spirochetal Lipoproteins and Immunity.Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis.Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit.Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans.Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis.
P2860
Q26863215-18F33E53-C671-4D16-A917-1F63A0FA782FQ30061569-491B432A-A7FA-4052-8C4E-B22AA42E9459Q33759102-3C3889E8-45E0-4CAA-B996-1E70285DEFE3Q34145626-0FB8980C-03BA-4C02-AC48-2059D0F55C79Q34419158-1CA63252-CAC2-4DEE-9627-9D2E97CB3921Q35867235-F09B43EC-123D-40F6-835B-7C319144BF70Q35940659-ADAC1997-B36B-4D1D-9318-BB82733B8F90Q36440093-C98DC722-6D95-419C-B4D3-40AAAB84DC97Q37712815-8CD5A3B1-30AF-4026-823D-7C79B2B7747FQ38234946-75F15938-19C2-46A0-BBD5-8ED5AEC8F1D7Q41630255-87AB8B08-5555-4A00-8DD4-CABAB3099379Q42672577-A52F0056-8B89-4992-991F-5567D1A99F6BQ54372379-B3BBF0F0-A622-4026-BAAC-ED52A209D8B5Q55485018-ED460F11-0ECC-4247-A701-5DEC3BC18A23
P2860
Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Evaluation of different ways o ...... vaccine against leptospirosis.
@en
Evaluation of different ways o ...... vaccine against leptospirosis.
@nl
type
label
Evaluation of different ways o ...... vaccine against leptospirosis.
@en
Evaluation of different ways o ...... vaccine against leptospirosis.
@nl
prefLabel
Evaluation of different ways o ...... vaccine against leptospirosis.
@en
Evaluation of different ways o ...... vaccine against leptospirosis.
@nl
P2093
P2860
P356
P1476
Evaluation of different ways o ...... vaccine against leptospirosis.
@en
P2093
Claudia Hartleben Fernandes
Daiane Drawanz Hartwig
Fabiana Kömmling Seixas
Fabricio Rochedo Conceição
José Antônio Guimarães Aleixo
P2860
P304
P356
10.1139/W06-138
P577
2007-04-01T00:00:00Z